838 results found View 10, 50, 100, 150 entries per page
Journal Year Drug Authors Title Source
N Engl J Med 2000 Paint Thinner Shannon M Ingestion of toxic substances by children N Engl J Med 2000 Jan 20; 342(3):186-91
Pediatrics 1998 Palivizumab The IMpact-RSV Study Group Palivizumab, a Humanized Respiratory Syncytial Virus Monoclonal Antibody, Reduces Hospitalization From Respiratory Syncytial Virus Infection in High-risk Infants Pediatrics 1998 Sep; 102(3): 531-7
Clin Neuropharmacol 2002 Palivizumab Mikati MA, Lepejian GA, Holmes GL Medical treatment of patients with infantile spasms Clin Neuropharmacol. 2002 Mar-Apr;25(2):61-71
Curr Opin Pulm Med 2002 Palivizumab Greenough A Respiratory syncytial virus infection: clinical features, management, and prophylaxis Curr Opin Pulm Med. 2002 May;8(3):214-7
Respir Med 2002 Palivizumab Simoes EA, Groothuis JR Respiratory syncytial virus prophylaxis--the story so far Respir Med. 2002 Apr;96 Suppl B:S15-24
Pediatr Infect Dis J 2002 Palivizumab Oh PI, Lanctjt KL, Yoon A, Lee DS, Paes BA, Simmons BS, Parison D, Manzi P; Composs Investigators Palivizumab prophylaxis for respiratory syncytial virus in Canada: utilization and outcomes Pediatr Infect Dis J. 2002 Jun;21(6):512-8
Pediatrics 2003 Palivizumab Prais D, Schonfeld T, Amir J; Israeli Respiratory Syncytial Virus Monitoring Group Admission to the intensive care unit for respiratory syncytial virus bronchiolitis: a national survey before palivizumab use Pediatrics. 2003 Sep;112(3 Pt 1):548-52
J Pediatr 2003 Palivizumab Feltes TF, Cabalka AK, Meissner HC, Piazza FM, Carlin DA, Top FH Jr, Connor EM, Sondheimer HM; Cardiac Synagis Study Group Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease J Pediatr. 2003 Oct;143(4):532-40
Pediatrics 2003 Palivizumab American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections. Pediatrics. 2003 Dec;112(6 Pt 1):1442-6.
Pediatrics 2003 Palivizumab Meissner HC, Long SS; American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial virus infections Pediatrics. 2003 Dec;112(6 Pt 1):1447-52